JERUSALEM (JTA) — The Technion-Israel Institute of Technology inaugurated the Technion Integrated Cancer Center, a hub for global cancer research.
The center opened this week and will, according to university officials, expedite the discovery of new diagnostic tools and treatments through a collaborative “bench-to-bedside” approach.
“Conquering cancer is one of the global community’s most pressing challenges, and it requires an interdisciplinary approach,” said Technion President Peretz Lavie.
“We need the collaboration between basic scientists, biochemists, cell biologists, computer scientists and experts in microscopy and imaging. We need the engineers, and we need the clinicians—and they are all at the Technion,” he said.
In addition to serving as a hub for multiple fields of research, the center also will serve as a nexus for the Technion’s five affiliated hospitals that run clinical trials.
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
